Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.0950
0.00 (0.00%)
Sep 10, 2026, 2:32 PM EST
Ventripoint Diagnostics Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.33 | 0.06 | 0.06 | 1.29 | 5.19 | 9.27 |
Cash & Short-Term Investments | 0.33 | 0.06 | 0.06 | 1.29 | 5.19 | 9.27 |
Cash Growth | 34.09% | -8.52% | -95.32% | -75.04% | -44.05% | 1662.07% |
Accounts Receivable | - | - | - | - | 0.04 | - |
Other Receivables | 0.08 | 0.13 | 0.25 | 0.29 | 0.33 | 0.2 |
Receivables | 0.08 | 0.13 | 0.25 | 0.29 | 0.37 | 0.2 |
Inventory | 0.09 | - | - | - | - | - |
Prepaid Expenses | 0.01 | 0.16 | 0.16 | 0.06 | 0.1 | 0.04 |
Total Current Assets | 0.52 | 0.35 | 0.47 | 1.64 | 5.66 | 9.5 |
Property, Plant & Equipment | 0.09 | 0.12 | 0.18 | 0.25 | 0.31 | 0.04 |
Total Assets | 0.61 | 0.47 | 0.66 | 1.88 | 5.98 | 9.54 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.51 | 1.36 | 1.7 | 0.95 | 0.84 | 0.99 |
Accrued Expenses | 0.31 | 0.6 | 0.29 | 0.3 | 0.12 | 0.06 |
Short-Term Debt | 2.45 | 2.4 | 1.34 | - | - | - |
Current Portion of Long-Term Debt | 0.03 | 0.02 | 0.02 | 0.06 | 0.05 | - |
Current Portion of Leases | 0.08 | 0.07 | 0.07 | 0.06 | 0.04 | 0.03 |
Current Unearned Revenue | 0.01 | 0.02 | 0.01 | 0.03 | - | - |
Total Current Liabilities | 4.39 | 4.47 | 3.43 | 1.4 | 1.06 | 1.09 |
Long-Term Debt | 0.02 | 0.04 | 0.06 | 0.08 | 0.09 | 0.13 |
Long-Term Leases | 0.04 | 0.08 | 0.15 | 0.22 | 0.27 | - |
Other Long-Term Liabilities | - | 0 | - | - | - | - |
Total Liabilities | 4.44 | 4.59 | 3.64 | 1.69 | 1.42 | 1.21 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 47.25 | 44.77 | 43.78 | 42.68 | 42.68 | 42.21 |
Additional Paid-In Capital | 11.83 | 12.22 | 11.61 | 10.91 | 10.42 | 9.76 |
Retained Earnings | -62.98 | -61.61 | -58.41 | -53.49 | -48.62 | -43.75 |
Comprehensive Income & Other | 0.06 | 0.51 | 0.05 | 0.09 | 0.08 | 0.11 |
Shareholders' Equity | -3.83 | -4.12 | -2.98 | 0.19 | 4.55 | 8.33 |
Total Liabilities & Equity | 0.61 | 0.47 | 0.66 | 1.88 | 5.98 | 9.54 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2.62 | 2.61 | 1.63 | 0.41 | 0.46 | 0.16 |
Net Cash (Debt) | -2.28 | -2.56 | -1.57 | 0.88 | 4.73 | 9.11 |
Net Cash Growth | - | - | - | -81.34% | -48.11% | - |
Net Cash Per Share | -0.01 | -0.02 | -0.01 | 0.01 | 0.03 | 0.07 |
Filing Date Shares Outstanding | 192.88 | 169.22 | 162.02 | 156.82 | 156.82 | 155.66 |
Total Common Shares Outstanding | 192.58 | 169.22 | 162.02 | 156.82 | 156.82 | 155.56 |
Working Capital | -3.87 | -4.12 | -2.95 | 0.24 | 4.61 | 8.42 |
Book Value Per Share | -0.02 | -0.02 | -0.02 | 0.00 | 0.03 | 0.05 |
Tangible Book Value | -3.83 | -4.12 | -2.98 | 0.19 | 4.55 | 8.33 |
Tangible Book Value Per Share | -0.02 | -0.02 | -0.02 | 0.00 | 0.03 | 0.05 |